Lenvatinib resistance mechanism and potential ways to conquer
Sign Up to like & getrecommendations! Published in 2023 at "Frontiers in Pharmacology"
DOI: 10.3389/fphar.2023.1153991
Abstract: Lenvatinib (LVN) has been appoved to treat advanced renal cell carcinoma, differentiated thyroid carcinoma, hepatocellular carcinoma. Further other cancer types also have been tried in pre-clinic and clinic without approvation by FDA. The extensive use… read more here.
Keywords: mechanism potential; ways conquer; lvn; resistance ... See more keywords